Wonik Q1 2026 Net Profit Plunges 63% on Equity Method Loss and Higher Costs

Consolidated Q1 2026: Revenue 36.96bn, Operating profit 2.67bn, Net profit (parent) 1.20bn (EPS 66 won) vs Q1 2025: Revenue 36.59bn, Net profit 3.23bn (EPS 177 won) – Net profit down 63%
Key drivers: Equity method loss 0.82bn (vs gain 1.68bn in prior), other non-operating expenses 0.22bn (donations etc.)
Segment operating profit: Healthcare/Trading 0.92bn (vs 1.04bn), Electronic components 1.50bn (vs 0.87bn), Other 0.25bn (vs 0.13bn)
Financial position: Debt ratio 37.1% (yearend 33.4%), Net debt ratio 18.2% (yearend 16.0%). Borrowings 55.7bn (yearend 48.1bn) increase
Inventory 28.45bn (yearend 20.76bn), Trade receivables 19.84bn (yearend 16.96bn) increase
Notable: Prior-period impairment of trademark rights 0.91bn and subsidiaries 0.69bn have no current impact